Site-Specific C-Terminal Labeling of Peptides and Proteins using Asparaginyl Endopeptidase in a Chemo-Enzymatic Sequence

16 August 2019, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Asparaginyl endopeptides (AEP) are recognized for their catalytic efficiency, presenting as ideal tools for protein bioconjugation. However, the peptide ligation catalyzed by AEP is reversible. In an attempt to obtain high reaction yields, thiodepsipeptides have been used as substrates but found to be highly unstable, and labeling is only limited to the N-terminus. To maximize the potential use of AEP, here we developed a novel chemo-enzymatic sequence for protein bioconjugation at both the N- and C-termini. In this system, an alternative recognition sequence, Asn-Cys-Leu, was used. Upon ligation, the reaction yields Cys-Leu as leaving group, and its reactive 1,2-aminothiol functionality was quenched by an effective and affordable electrophile, 2-formyl phenylboronic acid (FPBA), to yield a non-reactive cyclic byproduct. In the presence of FPBA our model reaction proceeds with ~95% yield using only 1.2 equivalent of substrate, whereas the yield remains at ~50% in the absence of this additive. This “quenching” approach enables protein labeling at both the N- and C-termini ranging from 75 to 85% (five examples). The simplicity and versatility of this quenching approach will enhance the future use of AEPs in protein bioconjugation.

Keywords

Peptide Ligation
protein bioconjugation
asparaginyl endopeptidase
enzyme
chemo-enzymatic

Supplementary materials

Title
Description
Actions
Title
AEP C-terminal bioconjugation SI
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.